eISSN: 2300-6722
ISSN: 1899-1874
Medical Studies/Studia Medyczne
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
2/2017
vol. 33
 
Share:
Share:
abstract:
Case report

Ventricular arrhythmias in a pregnant female – clinical implications

Ewelina Nowak
1
,
Marianna Janion
1, 2
,
Agnieszka Wencel-Wawrzeńczyk
3
,
Marek Sikorski
4
,
Izabela Wojarska
5

1.
Department of Internal Diseases, Cardiology and Medicine Nursing, Institute of Nursing and Midwifery, Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland
2.
2nd Department of Cardiology, Świętokrzyskie Cardiology Centre, Regional Hospital, Kielce, Poland
3.
Department of Midwifery, Gynecology and Midwifery-Gynecological Nursing, Institute of Nursing and Midwifery, Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland
4.
Department of Perinatology and Gynecological – Midwifery Nursing, Institute of Nursing and Midwifery, Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland
5.
Doctoral Studies, Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland
Medical Studies/Studia Medyczne 2017; 33 (2): 133–136
Online publish date: 2017/06/30
View full text Get citation
 
PlumX metrics:
Physiological changes occurring during pregnancy, at the time of childbirth, and in the postpartum period may influence the occurrence, and increase in intensity of, heart rhythm abnormalities. There is insufficient data on the safety and effectiveness of pharmacological treatment in the group of pregnant women. Cardiac arrhythmia induced by pregnancy rarely requires introduction of pharmaceuticals. It should be noted that most antiarrhythmic agents are not recommended for use during pregnancy and the breastfeeding period. In cases where a drug use is necessary, the most popular choice is -blockers or a calcium channel blocker – verapamil, which does not have teratogenic effects, but does get transferred to the mothers’ milk. The presented case study concerns a woman with no structural heart defects in her third pregnancy, with very ill-tolerated ventricular arrhythmia.
keywords:

pregnancy, pharmacotherapy, ventricular arrythmias

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.